Pharmalot Ed Silverman Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval
Adam's Take Adam Feuerstein In biotech, it pays to be bullish on Alzheimer’s trials, even when facts stand in the way
Pharmalot Ed Silverman FDA is offering a new approach for developing Alzheimer’s drugs. What could that mean?
Health Damian Garde Fans ‘didn’t care if he messed up’: Glen Campbell’s doctor discusses his struggle with Alzheimer’s
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Former compounder told staff to stop ‘fudging’ after meningitis outbreak
Signal Podcast Luke Timmerman and Meg Tirrell Listen: Episode 19: From poop transplants to pill politics, here’s the year in ‘Signal’
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Handful of doctors responsible for high levels of fentanyl prescriptions
In the Lab Sharon Begley Their brains had the telltale signs of Alzheimer’s. So why did they still have nimble minds?
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill
Business Rebecca Robbins Watch: Genetic tests promised to help me achieve peak fitness. What I got was a fiasco
Business Damian Garde A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it
In the Lab Usha Lee McFarling Peter Walter just won the Breakthrough Prize. His work? Trying to heal human brains
Health Dylan Scott Gene Wilder died of Alzheimer’s. His family explains why they didn’t disclose his diagnosis
Business Rebecca Robbins Athletes are keeping their distance from a genetic test for concussion risks
In the Lab Sharon Begley Alzheimer’s researchers seethe over years of missteps after latest drug failure
Health Megan Thielking $75 for reminders to eat: Alzheimer’s patients face flurry of fees while waiting for specialized care